Placing Value on Telemedicine for Inflammatory Bowel DiseaseSiegel, Corey A., MD, MSAmerican Journal of Gastroenterology: March 2019 - Volume 114 - Issue 3 - p 382–383 doi: 10.14309/ajg.0000000000000151 EDITORIAL Buy SDC Abstract Author InformationAuthors Article MetricsMetrics Telemedicine can take a number of forms. A popular approach is the use of telemonitoring, which takes advantage of available technology to follow patients remotely. Cross and colleagues present the results of a well-done randomized controlled trial to assess the impact of a telemonitoring program for patients with inflammatory bowel disease. They did not show a difference in disease activity, but this study leads us to question whether we know the appropriate outcomes to follow for telemedicine interventions. If we can show that telemedicine maintains quality of care at lower costs, the value of these types of interventions will ultimately be increased. Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA. Correspondence: Corey A. Siegel, MD, MS. E-mail: firstname.lastname@example.org. Received December 10, 2018 Accepted January 08, 2019 © The American College of Gastroenterology 2019. All Rights Reserved.